Hour24 News

Sophisticated and simple

NEWS

/

Biotech/Pharmaceuticals

Jan 13, 2026

Biotech/Pharmaceuticals /

Precigen Accelerates PAPZIMEOS Commercialization at 44th JP Morgan Conference, Driving Adoption for FDA-Approved RRP Therapy

Precigen Marks a New Era as a Commercial-Stage Biotech At the 44th Annual J.P. Morgan Healthcare Conference, Precigen showcased a pivotal shift from development-focused biotech…